U.S. Supreme Court to review lawsuits over flaws in generic drugs
The court agreed to review a bid by Mutual Pharmaceutical Co to overturn a $21 million jury award to Karen Bartlett, a New Hampshire woman who had taken its generic non-steroidal anti-inflammatory drug sulindac for shoulder pain.
LATEST NEW HAMPSHIRE ANGLE
Fosters: It’s too soon for the happy dance
New owners for Waukewan Golf Club
Reason.com - Brian Doherty: Cops may do bad things, but are white guys filming them worse?
Dunbarton egg farm denial brings lawsuit